Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederdrugs.com
Drugs.com - New Drug Approvals
Get the latest updates from Drugs.com - New Drug Approvals directly as they happen.
Follow now 76 followers
Latest posts
Last updated 2 days ago
FDA Approves Lynkuet (elinzanetant) for Moderate to Severe Hot Flashes Due to Menopause
3 days ago
WHIPPANY, N.J., October 24, 2025 – Bayer announced today the U.S. Food...
Blenrep Approved by US FDA for Use in Treatment of Relapsed/Refractory Multiple Myeloma
4 days ago
London, UK October 23, 2025 GSK plc (LSE/NYSE: GSK) today announced the...
FDA Approves Epioxa (riboflavin 5’-phosphate) Ophthalmic Solution for the Treatment of Keratoconus
7 days ago
Aliso Viejo, CA – October 20, 2025 – Glaukos Corporation (NYSE: GKOS)...
FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
9 days ago
South San Francisco, CA -- October 19, 2025 -- Genentech, a member...
FDA Approves Tezspire (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps
10 days ago
THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca...
FDA Approves Expanded Pediatric Indications for Yuflyma (adalimumab-aaty)
10 days ago
INCHEON, South Korea, Oct. 17, 2025 -- Celltrion, Inc. today announced that...
FDA Approves Rybelsus (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes Who Are at High Risk
10 days ago
PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Oct. 17, 2025 /PRNewswire/ -- Novo Nordisk...
FDA Approves Updated Indication Statement for Rinvoq (upadacitinib) for the Treatment of Inflammatory Bowel Disease
15 days ago
NORTH CHICAGO, Ill., Oct. 13, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...
FDA Approves Expanded Indication for Uzedy (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
18 days ago
PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE...
FDA Approves Jascayd (nerandomilast) to Treat Idiopathic Pulmonary Fibrosis
18 days ago
October 9, 2025 -- Boehringer Ingelheim’s Jascayd (nerandomilast) tablets has been approved...
FDA Approves Eydenzelt (aflibercept-boav), a Biosimilar to Eylea
19 days ago
INCHEON, South Korea, Oct. 9, 2025 /PRNewswire/ -- Celltrion, Inc. today announced...
Libtayo (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation
19 days ago
TARRYTOWN, N.Y., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ...